Back
Results - Announcements
Sales decline 4.19% to Rs 99.62 crore
Bharat Parenterals reports consolidated net loss of Rs 4.80 crore in the March 2026 quarter
19-May-2026, 07:24
Net Loss of Bharat Parenterals reported to Rs 4.80 crore in the quarter ended March 2026 as against net loss of Rs 4.73 crore during the previous quarter ended March 2025. Sales declined 4.19% to Rs 99.62 crore in the quarter ended March 2026 as against Rs 103.98 crore during the previous quarter ended March 2025.
Net Loss of Bharat Parenterals reported to Rs 4.80 crore in the quarter ended March 2026 as against net loss of Rs 4.73 crore during the previous quarter ended March 2025. Sales declined 4.19% to Rs 99.62 crore in the quarter ended March 2026 as against Rs 103.98 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 8.19 crore in the year ended March 2026 as against net loss of Rs 12.63 crore during the previous year ended March 2025. Sales rose 1.48% to Rs 345.43 crore in the year ended March 2026 as against Rs 340.38 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 99.62 | 103.98 | -4 | 345.43 | 340.38 | 1 |
| OPM % | -0.53 | 2.14 | - | 4.58 | 0.79 | - |
| PBDT | 0.26 | 0.22 | 18 | 12.83 | 1.37 | 836 |
| PBT | -8.37 | -8.30 | -1 | -21.42 | -33.95 | 37 |
| NP | -4.80 | -4.73 | -1 | -8.19 | -12.63 | 35 |
Powered by Capital Market - Live News